Bioqual, Inc.
BIOQ
Rank in Stocks
#24892
Bioqual, Inc. delivers a range of preclinical research solutions, encompassing... Bioqual, Inc. delivers a range of preclinical research solutions, encompassing both in-vivo and in-vitro methodologies, to its diverse clientele of commercial enterprises and government agencies across the United States. Their expertise spans numerous critical health domains, including investigations into COVID-19, AIDS, influenza, RSV infection, and various flaviviruses such as Zika and Dengue. Furthermore, their work extends to malaria, hepatitis, and oncology. The firm's comprehensive laboratory capabilities further include processing biological samples, producing virus stocks, precisely quantifying infectious viral loads, and conducting assays like virus neutralization and hemagglutination inhibition. They also utilize advanced techniques such as quantitative PCR, ELISA for antigen and antibody detection, flow cytometry, lymphocyte proliferation studies, and various other cell-based analytical methods. Moreover, Bioqual furnishes specialized support for studies employing animal research models. Established in 1981, Bioqual, Inc. maintains its primary operational base in Rockville, Maryland.
Share Price
$31.00
Last synced: 2026-11-17
Market Cap
$27.73M
Change (1 day)
0.00%
Change (1 year)
-19.50%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Bioqual, Inc. (BIOQ)
Category
Healthcare
Operating Margin for Bioqual, Inc. (BIOQ)
Operating Margin as of November 2026 TTM: -11.80%
According to Bioqual, Inc.'s latest financial reports, its current operating margin (TTM) is -11.80%. At the end of 2025 the company had an operating margin of -3.88%.
Operating Margin history for Bioqual, Inc. from 2001 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -11.80% | 204.12% |
| 2025 | -3.88% | 12,833.33% |
| 2024 | -0.03% | -101.70% |
| 2023 | 1.76% | -82.19% |
| 2022 | 9.88% | -33.38% |
| 2021 | 14.83% | 29.18% |
| 2020 | 11.48% | 26.43% |
| 2019 | 9.08% | -38.19% |
| 2018 | 14.69% | -17.84% |
| 2017 | 17.88% | 25.21% |
| 2016 | 14.28% | 27.39% |
| 2015 | 11.21% | 29.60% |
| 2014 | 8.65% | -1,518.03% |
| 2013 | -0.61% | -120.96% |
| 2011 | 2.91% | 2.11% |
| 2010 | 2.85% | -60.74% |
| 2007 | 7.26% | 22.02% |
| 2006 | 5.95% | -14.14% |
| 2005 | 6.93% | 1.76% |
| 2004 | 6.81% | 9.13% |
| 2003 | 6.24% | 34.48% |
| 2001 | 4.64% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 17.98% | -101.52% |
US
|
|
| 20.38% | -101.73% |
US
|
|
| 43.02% | -103.65% |
CN
|
|
| 32.30% | -102.74% |
US
|
|
| 22.23% | -101.88% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Bioqual, Inc.'s operating margin
What is Bioqual, Inc.'s operating margin?
Bioqual, Inc.'s operating margin is -11.80%, as of Nov 2026.
What was Bioqual, Inc.'s operating margin in 2025?
In 2025, Bioqual, Inc.'s operating margin was -3.88%, compared with -0.03% in 2024.
How has Bioqual, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Bioqual, Inc.'s operating margin was highest in 2021 (14.83%) and lowest in 2025 (-3.88%).
How does Bioqual, Inc.'s operating margin compare with similar companies?
Bioqual, Inc.'s operating margin (-11.80%) is lower than that of all 5 similar companies listed above. The highest among them is WuXi AppTec Co., Ltd., with 43.02%.